AVXL vs. KOD
AVXL (Anavex Life Sciences Corp.) and KOD (Kodiak Sciences Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, AVXL returned -31.28%/yr vs -13.09%/yr for KOD. Their 0.37 correlation means their historical movements had little consistent relationship.
Performance
AVXL vs. KOD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AVXL achieves a -22.75% return, which is significantly lower than KOD's 48.71% return.
AVXL
- 1D
- 1.85%
- 1M
- -0.36%
- 6M
- -41.49%
- YTD
- -22.75%
- 1Y
- -75.45%
- 3Y*
- -30.38%
- 5Y*
- -31.28%
- 10Y*
- -2.01%
- ALL TIME*
- -5.20%
KOD
- 1D
- -2.16%
- 1M
- 7.89%
- 6M
- 82.61%
- YTD
- 48.71%
- 1Y
- 525.26%
- 3Y*
- 140.21%
- 5Y*
- -13.09%
- 10Y*
- —
- ALL TIME*
- 19.98%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $2.44M | $2.45M | $3.31M | |
| $21.01M | $25.33M | $27.28M |
AVXL vs. KOD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
AVXL Anavex Life Sciences Corp. | -22.75% | -66.85% | 15.36% | 0.54% | -46.60% | 221.11% | 108.49% | 66.03% | -41.57% |
KOD Kodiak Sciences Inc. | 48.71% | 181.01% | 227.30% | -57.54% | -91.55% | -42.29% | 104.18% | 913.38% | -29.00% |
Correlation
The correlation between AVXL and KOD is 0.26, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.26 |
Correlation (3Y) Balances recent behavior with more history. | 0.34 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.42 |
Correlation (All Time) Calculated using the full available price history since Oct 4, 2018 | 0.37 |
The correlation between AVXL and KOD shifts across timeframes, from 0.26 (1 year) to 0.42 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
AVXL:
$254.85M
KOD:
$2.60B
AVXL:
-$0.38
KOD:
-$4.11
AVXL:
$0.00
KOD:
$0.00
AVXL:
$0.00
KOD:
-$26.49M
AVXL:
-$32.94M
KOD:
-$190.85M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AVXL vs. KOD — Risk / Return Rank
AVXL
KOD
AVXL vs. KOD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Anavex Life Sciences Corp. (AVXL) and Kodiak Sciences Inc. (KOD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AVXL | KOD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -5.01 | ||
| Sortino ratioReturn per unit of downside risk | -6.22 | ||
| Omega ratioGain probability vs. loss probability | 0.79 | 1.55 | -0.76 |
| Calmar ratioReturn relative to maximum drawdown | -0.95 | 14.82 | -15.77 |
| Martin ratioReturn relative to average drawdown | -1.28 | 34.23 | -35.51 |
Loading charts...
Drawdowns
AVXL vs. KOD - Drawdown Comparison
The maximum AVXL drawdown since its inception was -97.06%, roughly equal to the maximum KOD drawdown of -99.15%. Use the drawdown chart below to compare losses from any high point for AVXL and KOD.
Loading charts...
Drawdown Indicators
| AVXL | KOD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.06% | -99.15% | +2.09% |
Max Drawdown (1Y)Largest decline over 1 year | -79.38% | -36.24% | -43.14% |
Max Drawdown (3Y)Largest decline over 3 years | -82.62% | -81.10% | -1.52% |
Max Drawdown (5Y)Largest decline over 5 years | -89.96% | -98.91% | +8.95% |
Max Drawdown (10Y)Largest decline over 10 years | -91.89% | — | — |
Current DrawdownCurrent decline from peak | -90.47% | -74.72% | -15.75% |
Average DrawdownAverage peak-to-trough decline | -65.29% | -64.17% | -1.12% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 59.23% | 15.66% | +43.57% |
Volatility
AVXL vs. KOD - Volatility Comparison
Anavex Life Sciences Corp. (AVXL) has a higher volatility of 19.94% compared to Kodiak Sciences Inc. (KOD) at 15.41%. This indicates that AVXL's price experiences larger fluctuations and is considered to be riskier than KOD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AVXL | KOD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.94% | 15.41% | +4.53% |
Volatility (6M)Calculated over the trailing 6-month period | 62.12% | 76.15% | -14.03% |
Volatility (1Y)Calculated over the trailing 1-year period | 85.75% | 130.57% | -44.82% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 79.70% | 109.30% | -29.60% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 83.74% | 103.53% | -19.79% |
Dividends
AVXL vs. KOD - Dividend Comparison
Neither AVXL nor KOD has paid dividends to shareholders.
Financials
AVXL vs. KOD - Financials Comparison
This section allows you to compare key financial metrics between Anavex Life Sciences Corp. and Kodiak Sciences Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
AVXL and KOD have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AVXL has higher volatility (19.94%) compared to KOD (15.41%). In terms of maximum drawdown, AVXL dropped -97.06% vs KOD's -99.15%.
KOD currently has the higher Sharpe Ratio (4.13 vs -0.88), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AVXL and KOD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer